American Board of Chelation Therapy
The American Board of Chelation Therapy is now called the American Board of Clinical Metal Toxicology. This is because chelation therapy is essentially a treatment for the removal of toxic heavy metal elements from the body.
What Protocols are recommended for practitioners by the American Board
Of Chemical Toxicology to conduct Chelation Therapy?
The practitioner must be a DO and MD licensed to practice medicine. The doctor should have undergone a course on the diagnosis and treatment of metal toxicity. The doctor should have assisted a physician who is certified by the American Board of Clinical Metal Toxicology. The American Board of Clinical Metal Toxicology and the International Board of Clinical Metal Toxicology require physicians to submit evidence that they meet all the requirements before certification.
What is the Purpose of the American Board of Clinical Metal Toxicology?
The purpose of the American Board of Clinical Metal Toxicology is to discipline, monitor, and improve the standards of care in clinical metal toxicology. The Board governs the research in chelation therapy both in the areas of physician experience and patient outcomes.
What are the functions of the American Board of Clinical Metal Toxicology?
The American Board of Clinical Metal Toxicology is the governing body of chelation therapy practitioners. It has conducted a course and certified doctors for 24 years in the discipline of metal toxicology. Strict protocols are designed by the board to be followed by all chelation therapists. Only Physicians who are DOs and MDs can practice chelation therapy under the licensing rules of the board. In 1982 the American Board of Clinical Metal Toxicology began licensing and certifying physicians who conduct chelation therapy as a means of heavy metal detoxification. The board makes rules conducts seminars and workshops to continuously monitor research, practices, and developments in the therapeutic effects of chelation. Research is being conducted under the aegis of the FDA and the National Institute of Health with regard to whether chelation therapy will be a miracle treatment for patients with coronary arterial disease. When research becomes proof, the board will license and train physicians to use chelation therapy as a procedure to treat heart patients. The board authorizes and approves of training seminars and conducts examinations for physicians in conformity with the by laws of the board. The board has a website where a list of licensed physicians is given for the ready reference of patients.
What precautions are required under the rules of the American Board of Clinical Metal Toxicology before conducting Chelation Therapy?
Under the rules of the American Board of Clinical Metal Toxicology a patient should have a blood and urine test conducted to check the level of toxins. If the patient is pregnant, lactating, diabetic or suffering from heart or kidney disease, chelation therapy should not be conducted. The fact that chelation therapy is not evaluated by the FDA should be communicated to the patient. The patient should be treated as an out patient and the session should last one to one and a half hours. 20-30 sessions should be conducted. The doctor must inform the
patient that the therapy may not prevent, treat or cure any disease. The purpose of chelation therapy is merely to detoxify the body from metal toxins.
All therapies and therapists require a governing body. The purpose of the American Board of Clinical Metal Toxicology is the governing board for the regulation of chelation therapeutic methods and chelation therapists.
Nature's Way - Potassium Chelate, 99 mg, 100 capsules